Concepedia

Suresh Kapadia

SK

Statistics

Publications

19

Citations

1.2K

H-Index

16

Active since

1992

Affiliations

Boehringer Ingelheim (United States)(Current)

Boehringer Ingelheim (Japan)

Suresh Kapadia is an author at Boehringer Ingelheim (United States) specializing in chemistry, medicinal chemistry, and organic chemistry.

Publications per year

1992–2020

19

Publications

19

On the Nature of the "Copper Effect" in the Stille Cross-Coupling

Vittorio Farina, Suresh Kapadia, Bala Krishnan et al. · The Journal of Organic Chemistry · 1994 · 501 citations

, , +8

Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2. Tricyclic pyridobenzoxazepinones and dibenzoxazepinones

Janice M. Klunder, Karl D. Hargrave, M. L. WEST et al. · Journal of Medicinal Chemistry · 1992 · 144 citations · Full text

, , +13

Discovery of 2-Phenylamino-imidazo[4,5-<i>h</i>]isoquinolin-9-ones:  A New Class of Inhibitors of Lck Kinase

Roger J. Snow, Mario Cardozo, Tina M. Morwick et al. · Journal of Medicinal Chemistry · 2002 · 63 citations · Full text

, , +14

A Novel Method for the Asymmetric Synthesis of α,α-Disubstituted Alkylamines <i>via</i> Grignard Additions to Ketimines

Denice M. Spero, Suresh Kapadia · The Journal of Organic Chemistry · 1997 · 48 citations

, , +12

Optimization of 2-Phenylaminoimidazo[4,5-<i>h</i>]isoquinolin-9-ones:  Orally Active Inhibitors of lck Kinase

Daniel R. Goldberg, Tanja Butz, Mario Cardozo et al. · Journal of Medicinal Chemistry · 2003 · 45 citations · Full text

, , +12

1–5 of 19